<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2020 [PPXK611ND10HVJVXHM1C]. www.edgarsuite.com -->
<HEAD>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P align=center style='font:14pt Times New Roman;margin:0'><B>UNITED STATES </B></P>
<P align=center style='font:14pt Times New Roman;margin:0'><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P align=center style='font:15pt Times New Roman;margin:0'><B>Washington, D.C. &nbsp;20549</B></P>
<P align=center style='font:15pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:14pt Times New Roman;margin:0'><B>FORM 8-K</B></P>
<P align=center style='font:14pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:14pt Times New Roman;margin:0'><B>CURRENT REPORT</B></P>
<P align=center style='font:14pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>Date of Report (date of earliest event reported): &nbsp;<B>July 28, 2020</B></P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0;margin-right:72pt'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:468pt><TR><TD colspan=5 valign=top style=width:468pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:14pt Times New Roman;margin:0'><B>UTAH MEDICAL PRODUCTS, INC.</B></P>
</TD></TR>
<TR><TD colspan=5 valign=top style=width:468pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:9pt Times New Roman;margin:0'>(Exact name of registrant as specified in its charter)</P>
</TD></TR>
<TR><TD valign=top style=width:147.95pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.15pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:147.95pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:11pt Times New Roman;margin:0'><B>Utah</B></P>
</TD><TD valign=top style=width:12.15pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'><B>000-12575</B></P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'><B>87-0342734</B></P>
</TD></TR>
<TR><TD valign=top style=width:147.95pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:9pt Times New Roman;margin:0'>(State or other jurisdiction of</P>
</TD><TD valign=top style=width:12.15pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>(Commission File Number)</P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>(IRS Employer</P>
</TD></TR>
<TR><TD valign=top style=width:147.95pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:9pt Times New Roman;margin:0'>incorporation or organization)</P>
</TD><TD valign=top style=width:12.15pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>Identification No.)</P>
</TD></TR>
<TR><TD valign=top style=width:147.95pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.15pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD colspan=3 valign=top style=width:308pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style=font-size:12pt><B>7043 South 300 West</B></FONT></P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD colspan=3 valign=top style=width:308pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style=font-size:12pt><B>Midvale, Utah </B></FONT></P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style=font-size:12pt><B>84047</B></FONT></P>
</TD></TR>
<TR><TD colspan=3 valign=top style=width:308pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:9pt Times New Roman;margin:0'>(Address of principal executive offices)</P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>(Zip code)</P>
</TD></TR>
<TR><TD colspan=3 valign=top style=width:308pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD colspan=3 valign=top style=width:308pt;padding-left:0.7pt;padding-right:0.7pt><P style='font:11pt Times New Roman;margin:0'>Registrant&#8217;s telephone number, including area code: &nbsp;</P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style=font-size:12pt><B>Phone: </B><B>(801) 566-1200</B></FONT></P>
</TD></TR>
<TR><TD colspan=3 valign=top style=width:308pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:147.9pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD colspan=5 valign=top style=width:468pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:12pt Times New Roman;margin:0'><B>n/a</B></P>
</TD></TR>
<TR><TD colspan=5 valign=top style=width:468pt;padding-left:0.7pt;padding-right:0.7pt><P align=center style='font:11pt Times New Roman;margin:0'>(Former name or former address, if changed since last report)</P>
</TD></TR>
</TABLE>
<P align=justify style='font:11pt Times New Roman;margin:0;margin-right:72pt'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse><TR><TD valign=top style=width:27.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>[&#160;&#160;]</P>
</TD><TD valign=top style=width:450.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
</TD></TR>
<TR><TD valign=top style=width:27.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:450.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:27.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>[&#160;&#160;]</P>
</TD><TD valign=top style=width:450.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
</TD></TR>
<TR><TD valign=top style=width:27.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:450.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:27.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>[&#160;&#160;]</P>
</TD><TD valign=top style=width:450.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
</TD></TR>
<TR><TD valign=top style=width:27.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:450.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:27.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>[&#160;&#160;]</P>
</TD><TD valign=top style=width:450.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
</TD></TR>
<TR><TD valign=top style=width:27.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:450.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD colspan=2 valign=top style=width:478.8pt><P align=justify style='font:11pt Times New Roman;margin:0'>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).</P>
</TD></TR>
<TR><TD valign=top style=width:27.9pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:450.9pt><P align=right style='font:11pt Times New Roman;margin:0'>Emerging growth company [&#160;&#160;]</P>
</TD></TR>
<TR><TD colspan=2 valign=top style=width:478.8pt><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD colspan=2 valign=top style=width:478.8pt><P style='font:11pt Times New Roman;margin:0'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&#160;&#160;]</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'><B>ITEM 2.02&#8212;RESULTS OF OPERATIONS AND FINANCIAL CONDITION</B></P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and six months ended June 30, 2020 and forward-looking statements relating to 2020 and beyond as presented in a press release dated June 30, 2020. &nbsp;The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, as amended, except to the extent that such information is superseded by information as of a subsequent date that is included in or incorporated by reference into such registration statement. The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><B>ITEM 9.01&#8212;FINANCIAL STATEMENTS AND EXHIBITS</B></P>
<P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>The following is filed as an exhibit to this report: &nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:476pt><TR><TD valign=top style='width:59.75pt;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><B>Exhibit</B></P>
<P align=center style='font:11pt Times New Roman;margin:0'><B>Number*</B></P>
</TD><TD valign=top style=width:12.5pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:329.5pt;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><B>Title of Document</B></P>
</TD><TD valign=top style=width:12.5pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:61.75pt;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><B>Location</B></P>
</TD></TR>
<TR><TD valign=top style=width:59.75pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'><B>Item 99.1</B></P>
</TD><TD valign=top style=width:12.5pt;padding-left:5.75pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:329.5pt;padding-left:5.75pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'><A href=utah_ex99z1.htm style=text-decoration:none><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'>Financial information for Utah Medical Products, Inc.</FONT></A> for the three and six months ended June 30, 2020 and forward-looking statements relating to 2020 and beyond as presented in a press release dated July 28, 2020.</P>
</TD><TD valign=top style=width:12.5pt;padding-left:5.75pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:61.75pt;padding-left:5.75pt;padding-right:5.75pt><P style='font:11pt Times New Roman;margin:0'>This filing</P>
</TD></TR>
<TR><TD valign=top style=width:59.75pt;padding-left:5.75pt;padding-right:5.75pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.5pt;padding-left:5.75pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:329.5pt;padding-left:5.75pt;padding-right:5.75pt><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.5pt;padding-left:5.75pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:61.75pt;padding-left:5.75pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P align=justify style='font:11pt Times New Roman;margin:0;text-indent:-18pt;margin-left:18pt'>_______________________________________</P>
<P align=justify style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt;margin-left:18pt'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:-18pt'>*</KBD>All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. &nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt;text-indent:-18pt;margin-left:18pt'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><B>SIGNATURES</B></P>
<P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse><TR><TD valign=top style=width:234.05pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=top style=width:244.75pt;padding-left:0.7pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'><B>UTAH MEDICAL PRODUCTS, INC.</B></P>
</TD></TR>
<TR><TD valign=top style=width:234.05pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=top style=width:244.75pt;padding-left:0.7pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:234.05pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=top style=width:244.75pt;padding-left:0.7pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:234.05pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=top style=width:244.75pt;padding-left:0.7pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:234.05pt><P align=justify style='font:11pt Times New Roman;margin:0'>Dated: July 28, 2020</P>
</TD><TD valign=top style=width:26.7pt;padding-left:0.7pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'>By:</P>
</TD><TD valign=top style='width:218.05pt;border-bottom:0.5pt solid #000000'><P align=justify style='font:11pt Times New Roman;margin:0'>/s/ Kevin L. Cornwell</P>
</TD></TR>
<TR><TD valign=top style=width:234.05pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:26.7pt;padding-left:0.7pt;padding-right:5.75pt><P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:218.05pt;border-top:0.5pt solid #000000'><P align=justify style='font:11pt Times New Roman;margin:0'>Kevin L. Cornwell, Chief Executive Officer</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'></DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "utah_8k.htm", "description": "UTAH MEDICAL 8-K", "secsgml_size_bytes": 21267}]
{"company-data": {"conformed-name": "UTAH MEDICAL PRODUCTS INC", "cik": "0000706698", "assigned-sic": "3841", "irs-number": "870342734", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-12575", "film-number": "201053006"}, "business-address": {"street1": "7043 S 300 WEST", "city": "MIDVALE", "state": "UT", "zip": "84047", "phone": "8015661200"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
July 28, 2020
UTAH MEDICAL PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
Utah
000-12575
87-0342734
(State or other jurisdiction of
(Commission File Number)
(IRS Employer
incorporation or organization)
Identification No.)
7043 South 300 West
Midvale, Utah
84047
(Address of principal executive offices)
(Zip code)
Registrant's telephone number, including area code:
Phone:
(801) 566-1200
n/a
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).
Emerging growth company [  ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]
ITEM 2.02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and six months ended June 30, 2020 and forward-looking statements relating to 2020 and beyond as presented in a press release dated June 30, 2020.  The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, as amended, except to the extent that such information is superseded by information as of a subsequent date that is included in or incorporated by reference into such registration statement. The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.
ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS
The following is filed as an exhibit to this report:
Exhibit
Number*
Title of Document
Location
Item 99.1
Financial information for Utah Medical Products, Inc.
for the three and six months ended June 30, 2020 and forward-looking statements relating to 2020 and beyond as presented in a press release dated July 28, 2020.
This filing
_______________________________________
*
All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
UTAH MEDICAL PRODUCTS, INC.
Dated: July 28, 2020
By:
/s/ Kevin L. Cornwell
Kevin L. Cornwell, Chief Executive Officer